Cochlear (ASX:COH) Shares Pass Above 200-Day Moving Average of $195.71

Cochlear Limited (ASX:COH) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $195.71 and traded as high as $211.75. Cochlear shares last traded at $211.68, with a volume of 228,557 shares.

The stock has a market cap of $12.23 billion and a PE ratio of 44.15. The stock has a fifty day simple moving average of A$216.95 and a two-hundred day simple moving average of A$195.71. The company has a debt-to-equity ratio of 25.02, a quick ratio of 1.14 and a current ratio of 1.77.

The business also recently declared a Final dividend, which will be paid on Monday, October 14th. Shareholders of record on Monday, October 14th will be issued a $1.75 dividend. This represents a yield of 0.8%. The ex-dividend date of this dividend is Thursday, September 19th. Cochlear’s dividend payout ratio is presently 68.82%.

In other Cochlear news, insider Shah Abbas Hussain bought 160 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were bought at an average cost of A$217.18 ($154.02) per share, with a total value of A$34,748.00 ($24,643.97). Also, insider Dig Howitt sold 8,227 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of A$211.15 ($149.75), for a total value of A$1,737,131.05 ($1,232,007.84).

Cochlear Company Profile (ASX:COH)

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories.

Further Reading: Mutual Funds

Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with's FREE daily email newsletter.